Editas Medicine
IPOTranslating CRISPR genome editing into medicines
Public · Cambridge, United States · Founded 2013 · $163.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 201–500
- Founded
- 2013
- Business Model
- B2B
- Website
- editasmedicine.com
- Total Funding
- $163.0M
- Last Round
- $120.0M Series BAug 2015
- Rounds
- 2
- Type
- Public
About
Editas Medicine is a leading gene editing company founded in 2013, HQ Cambridge Massachusetts. Translates CRISPR genome editing into medicines for serious diseases using CRISPR/Cas9 and Cas12a nucleases. Focus on hemoglobinopathies (sickle cell, beta thalassemia), cardiovascular diseases, and oncology. Went public February 2016.
Summary
Editas Medicine is a Biotech company based in Cambridge, United States, founded in 2013. It has raised $163.0M in total across 2 rounds, most recently a $120.0M Series B round in Aug 2015. Investors include Flagship Pioneering, Morgan Stanley and J.P. Morgan.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Feb 2016
Sign up to see all 3 rounds
Series A through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/editas-medicine"><img src="https://indexed.vc/api/badge/company/editas-medicine" alt="Editas Medicine on Indexed.vc" width="260" height="76" /></a>